Gilead Sciences | Zobowiązania Handlowe



Trade Creditors Zmiana Data
AbbVie 2.94B 2.66B 2024-12
Agios Pharmaceuticals USD 13.73M 2.92M 2025-03
ALKERMES USD 59.84M 14.21M 2025-03
Alnylam Pharmaceuticals USD 97.4M 8.98M 2025-03
Amgen USD 2.41B 498M 2025-03
Biogen USD 391.5M 32.7M 2025-03
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Bristol-Myers Squibb USD 4B 400M 2025-03
Eli Lilly USD 3.44B 213.4M 2025-03
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.15B 186M 2025-03
Glaxosmithkline 3.46B 10.01B 2024-12
Incyte USD 195.54M 1.93M 2025-03
J&J USD 9.54B 766M 2025-03
Merck USD 3.78B 295M 2025-03
Moderna USD 226M 179M 2025-03
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.24B 393M 2025-03
PTC Therapeutics USD 15.15M 2.12M 2025-03
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Sanofi 21.62B 14.07B 2025-03
Sarepta Therapeutics USD 156.1M 58.34M 2025-03
United Therapeutics 6M 357.9M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Gilead Sciences Zobowiązania Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.